LEADER 03120nam  2200337   450 
001 9910688202203321
005 20230628203927.0
035   $a(CKB)5400000000043684
035   $a(NjHacI)995400000000043684
035   $a(EXLCZ)995400000000043684
100   $a20230628d2015      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBiofilm-Based Nosocomial Infections /$fGianfranco Donelli
210  1$a[Place of publication not identified] :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2015.
215   $a1 online resource (238 pages)
311   $a3-03842-136-7 
330   $aThe well-known persistence in the nosocomial environment of multidrug resistant bacterial and fungal species, today responsible for a wide variety of healthcare-associated infections, is believed to be greatly promoted by the ability of most of them to adhere and to grow in sessile mode on mucosal and soft tissues of hospitalized patients, as well as on the inner and outer surfaces of indwelling medical devices, including intravenous catheters, orthopaedic, cardiac valves, intrauterine devices, and contact lenses. In this regard, a large number of these microorganisms, such as Acinetobacter baumannii, Candida albicans, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus, give rise to highly organized, sessile community defined biofilms, in which microbes grow encased in a hydrated matrix of extracellular polymeric substances produced by themselves and are well protected from the attack of antimicrobial molecules and from the host immune response, by resisting phagocytosis and other body's defense systems. The great influence of the sessile growth on the effectiveness of the antibiotic therapies is due to both the structure and function of these microbial communities, making these also 1000 times more tolerant to antibiotics and disinfectants. Thus, alternative approaches to the common antibiotic treatments are emerging for preventing and treating both the mono-species and the most frequent multi-species biofilms, including enzymes able to disrupt mature biofilms and new biomaterials for the coating of medical devices to counteract microbial adhesion and biofilm formation. The aim of this Special Issue is to report on the state-of-art of the basic and applied research in the field of biofilm-based nosocomial infections that can be acquired by patients in both general hospitals and long-term care settings. Particularly, the involvement of microbial biofilms in medical device-related infections and other healthcare-associated infections, so far underestimated and/or scarcely investigated, has been considered, reviewed, and discussed.
606   $aNosocomial infections
615  0$aNosocomial infections.
676   $a614.44
700   $aDonelli$b Gianfranco$0272755
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688202203321
996   $aBiofilm-Based Nosocomial Infections$93395358
997   $aUNINA